A B S T R A C T To determine if previously reported peripheral blood suppressor cell defects are also found in the central nervous system (CNS) of patients with multiple sclerosis (MS), we studied cerebrospinal fluid (CSF) and peripheral blood lymphocytes from 40 MS patients and 15 patients with other neurological diseases. With an indirect immunofluorescence technique using the OKT series of monoclonal antibodies (OKT4, marking helper/inducer cells, OKT5 and OKT8 marking suppressor/cytotoxic cells, and OKT3 marking all peripheral T cells) we found that MS patients tested in the first 2 wk of exacerbation had invariably diminished CSF suppressor/cytotoxic cells, which was followed by an elevation of these cells in the 3rd wk of exacerbation. Repeat studies of three patients showed that perturbations of CSF suppressor/cytotoxic cells were dependent on clinical status. These observations add to the accumulating data that suggest altered immunity in the pathogenesis of MS.
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INTRODUCTION
Multiple sclerosis (MS)' is a disease characterized by episodic central nervous system (CNS) demyelination, the mechanism and etiology of which are poorly understood; current hypotheses favor a primary role for altered immunity against viral and/or self-antigens (reviewed in references 1 and 2). The plethora of reports of abnormal humoral immunity in MS-including raised titers of antibodies to measles and other viruses (1) and antibodies to several CNS components (2, 3)-has been followed in recent years by reports of cellular immune abnormalities (2, (4) (5) (6) (7) (8) (9) (10) (11) . One of the most consistent and attractive findings relates to suppressor cells; most studies agree that circulating suppressor cell numbers (measured by membrane markers) (5, (8) (9) (10) (11) and suppressor cell function (determined in various in vitro systems) (4, 6, 7) are altered during the acute phases of MS. It is theorized that a loss of suppression in MS may indicate a deregulation of immune "homeostasis" in the CNS, permitting an uncontrolled immune response to self or viral antigens (10, 11) .
One major problem with the above studies is that the peripheral blood (PB), where suppressor markers and function have been measured, may not accurately reflect the immune perturbations that accompany MS at the site of its target organ. A study of the cerebrospinal fluid (CSF), which may be considered a "sink" for humoral (12) and cellular (13, 14) processes occuring in the CNS, might answer this question.
Recently, purified heteroantisera and monoclonal antibodies have made it possible to distinguish immunoregulatory lymphocyte subsets that had been previously defined by functional properties or by physiologically labile membrane markers (15) . Disturbances of immunoregulatory cell subset composition have been reported in a variety of diseases using an indirect immunofluorescence technique with manual or automated counting of labeled cells (16, 17) .
In PB mononuclear cell isolation and phenotyping. 10-15 ml of blood was obtained from patients within an hour of lumbar puncture. PB mononuclear cells were isolated and phenotyped as already described (11, 16) .
Calculations. When possible, a OKT4+/OKT8+ index was computed from the OKT4+ and OKT8+ percentages. A helper/suppressor cell ratio is thought to diminish the influence of nonlymphoid contaminating cells on the absolute percentage of labeled cells (10, 11) . Data were analyzed with Student's two-tailed t test.
RESULTS
CSF T cell subsets in OND and MS (Table I, Fig.  IA ). We studied 15 OND patients with a variety of inflammatory and noninflammatory diseases. Two patients (neurosyphilis, CNS sarcoidosis) has CSF lymphocyte counts >5 cells/mm3. OKT3+ cells ranged from 83% (sciatica) to 96% (CNS sarcoidosis). Immunoregulatory cell subset composition ranged widely, as indicated by the percentages of OKT4+, OKT5+, OKT8+ cells, and the OKT4+/OKT8+ index. Interestingly, there was no correlation between any immunoregulatory cell percentage and the CSF lymphocyte count in OND and MS patients, indicating that immunoregulatory subset composition is probably independent of the number of cells that reach the CSF from the parenchyma.
MS remission patients had a T-cell subset pattern that was not significantly different from that of the OND group. A clear pattern of CSF lymphocyte subset distribution was seen when patients with exacerbating MS were divided into three groups according to their proximity in time to exacerbation: group I from 2 wk before to 2 wk after the onset of exacerbation, group II in their 3rd wk of exacerbation, and group III from the 4th wk to 6 mo after the onset of exacerbation. Exacerbation is dated from the patient's reported date of onset.
All group I exacerbation patients had CSF OKT8+ cell percentages <20%, which was a significant depression compared with OND and remission patients (P < 0.001 for both groups). In addition OKT5+ cells were significantly depressed when compared with OND and remission patients (P < 0.02 and < 0.05, respectively), and the OKT4+/OKT8+ index was significantly elevated when compared with OND and remission patients (P < 0.001 and < 0.01, respectively).
An unexpected but highly significant finding was made when patients in their 3rd wk of exacerbation were grouped for analysis (group II). The majority of these patients had >30% OKT8+ cells in the CSF and two patients exceeded 40%. The difference between this group and group I patients was significant for OKT8+ cells (P < 0.001), OKT5+ cells (P < 0.05), and the OKT4+/OKT8+ index (P < 0.001). The mean OKT8+ cell percentage in group II patients was higher than in OND, but the difference was not statistically significant. The elevation in the percentage of OKT8+ cells cannot -eye- PB T cell subsets in OND and MS (Table II, Fig.  JB) . PB values only partly reflected immunoregulatory cell subset perturbations in the CSF. When PB data were arranged in the three groups described above, there were depressions in OKT3+, OKT4+, OKT5+, and OKT8+ cells, and an elevation of the OKT4+/OKT8+ index in group I patients compared with OND. However, none of these changes reached statistical significance, due to a significant proportion of patients (5 out of 11) whose T cell subset composition was normal.
Patients tested more than once (Table III) . Two OND patients were tested two times in the course of their diseases at least 1 mo apart (second determinations are not included in the OND data). A patient with CNS sarcoidosis and a patient with neurosyphilis showed <8% fluctuation of OKT markers, despite a depression of CSF lymphocytes with therapy in both cases.
In contrast, when three patients with MS were tested more than once, acute exacerbation was associated with increased OKT3+ cells and depressed OKT8+ This finding is also supported by our data.
The initial depression of OKT8+ cells in the CSF and PB during exacerbation could reflect a depression in suppressor activity in the CNS, leading to an increased immune response to certain antigens, as observed in a variety of autoimmune diseases (16) . Sim- ilarly, the elevation of OKT8+ cells observed in some patients in the 3rd wk of exacerbation may indicate a rebound of suppressor cells entering the CNS, or proliferation from clones already in the CNS. This may have the effect of restoring immunoregulatory equilibrium between suppressor and helper cells and, thus, down regulating the immune response in the CNS. However, it should be stressed that the monoclonal antibodies OKT8 and OKT5 mark both suppressor and cytotoxic T cells (20) . It is not known if OKT8+ cells can be separated into two functional subsets or if the same cell mediates both T-cell suppression and T-cell cytotoxicity. Thus, the OKT8+ cell peak may represent a migration or proliferation of cytotoxic T cells that are marshalled to respond to a CNS pathogen. It is interesting to note that an increase in OKT8+ cell has also been reported in several viral infections (15) .
In conclusion, our data indicate immunoregulatory cell perturbations in the CSF of patients with MS that are not always reflected in the PB. A highly significant depression of suppressor/cytotoxic cells was present without exception in MS patients with acute exacerbation who were tested within 2 wk before or after the onset of exacerbation. In addition, we report a peak of CSF OKT8+ cells occurring in the 3rd wk of exacerbation that may be associated with amelioration. These data suggest that immune mechanisms are involved in the production of the MS plaque, and, further, the hope that specific immunomodulatory treatments may soon be developed to alter the course of MS.
